BridgeMD
New treatment option for Stroke Rehabilitation
Official title Substrates for Post-Stroke Arm Rehabilitation
ClinicalTrials.gov ID: NCT06998485
What this study is testing
- What it's testing
- Difficulty moving the arm is very common and a major cause of disability after stroke. Although rehabilitation therapies (i.e., occupational and physical therapy) are the most common treatments used to improve arm motor function, it remains unknown how therapy actually changes brain pathways after stroke.
- Time commitment: about 6 weeks
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- first time unilateral ischemic or hemorrhagic stroke occurring within the 3-6 months
- upper extremity motor impairment as measured by the Upper Extremity Fugl-Meyer Assessment (UE-FMA) Score \<= 44
- ability to participate in a 6-week intensive upper extremity intervention in English as determined by a licensed occupational therapist.
You likely can't join if
- bilateral stroke
- unstable medical status affecting functional status
- pre-stroke upper extremity injury or conditions that limited use
- visual or auditory impairment limiting ability to participate in study procedures
- significant aphasia (NIHSS sub-item 9 \> 1) or cognitive (NIHSS 1a or 1b or 1c \> 1) deficits
- known or expected inability to maintain follow-up through the study intervention and post- assessment
See the full eligibility criteria
- first time unilateral ischemic or hemorrhagic stroke occurring within the 3-6 months
- upper extremity motor impairment as measured by the Upper Extremity Fugl-Meyer Assessment (UE-FMA) Score \<= 44
- ability to participate in a 6-week intensive upper extremity intervention in English as determined by a licensed occupational therapist.
- bilateral stroke
- unstable medical status affecting functional status
- pre-stroke upper extremity injury or conditions that limited use
- visual or auditory impairment limiting ability to participate in study procedures
- significant aphasia (NIHSS sub-item 9 \> 1) or cognitive (NIHSS 1a or 1b or 1c \> 1) deficits
- known or expected inability to maintain follow-up through the study intervention and post- assessment
- contraindications to MRI
- contraindications to TMS
- known history of uncontrolled seizure disorder.
The study team makes the final eligibility decision.
Where it's taking place
- Boston, Massachusetts, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The study runs about 6 weeks per participant, based on its public description. The team confirms the exact schedule and number of visits before you enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Boston, Massachusetts, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.